Therapeutic Asset Ratings
5,108 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
(+)-VINCRISTINE
Gliosarcoma
RTOG Foundation, Inc.
P3
BB
(67)
(+)-VINCRISTINE
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
AstraZeneca
P3
BB
(67)
VINCRISTINE SULFATE
Lymphoblastic Lymphoma
City of Hope Medical Center
P3
BB
(67)
VINCRISTINE SULFATE
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(67)
VINCRISTINE SULFATE
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
P3
BB
(67)
VIPIVOTIDE TETRAXETAN
Prostate Adenocarcinoma
Mayo Clinic
P3
BB
(67)
Zanubrutinib
Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P3
BB
(67)
Zanubrutinib
Marginal Zone Lymphoma
Zhengzhou University
P3
BB
(67)
Zuranolone
Major Depressive Disorder
Biogen
P3
BB
(67)
4,5,7,4',5',7'-HEXAHYDROXY-2,2'-DIMETHYLNAPHTHODIANTHRONE
Mycosis Fungoides
Soligenix
P3
BB
(66)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Cerebrovascular Disorder
Zhejiang Provincial People's Hospital
P3
BB
(66)
9-valent human papillomavirus recombinant vaccine
Anal Canal Carcinoma In Situ
Xiamen University
P3
BB
(66)
Acasunlimab
Non-Small Cell Lung Carcinoma
Genmab
P3
BB
(66)
Acp-204
Alzheimer Disease
ACADIA Pharmaceuticals Inc.
P3
BB
(66)
Adebrelimab
Non-Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute
P3
BB
(66)
Admilparant
Pulmonary Fibrosis
Bristol-Myers Squibb
P3
BB
(66)
AK105
Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
BB
(66)
Alpelisib
HER2 Positive Breast Carcinoma
Criterium, Inc.
P3
BB
(66)
Alxn1840
Wilson Disease
Alexion Pharmaceuticals, Inc.
P3
BB
(66)
AMINO ACIDS,ESSENTIAL
Metabolic Dysfunction-Associated Steatotic Liver Disease
Michigan State University
P3
BB
(66)
Amrecibart
Atrial Fibrillation
Regeneron Pharmaceuticals
P3
BB
(66)
ANASTROZOLE
Metastatic Malignant Neoplasm
UNICANCER
P3
BB
(66)
ANTI-PD-L1 MONOCLONAL ANTIBODY SHR-1316
Triple-Negative Breast Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P3
BB
(66)
ASPARAGINASE
Down Syndrome
National Hospital Organization Nagoya Medical Center
P3
BB
(66)
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
Down Syndrome
National Cancer Institute (NCI)
P3
BB
(66)
Showing 951 to 975 of 5,108 assets
Previous
Page 39 of 205
Next